Common characteristics of IE-IRFs
| Gene | IRF1 | IRF3 | IRF4 | IRF6 | IRF7 | IRF8 | IRF9 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inheritance pattern | AR | AD (HSE) | AD | AD (T95R) | AD (F359L) | AD (R98W) | AR (V405Gfs Ter127) | AD (VWS) | AD (PPS) | AR | AD | AR | AD | AR | |
| Mechanism | LOF | HI | HI | MM | MM | HI | UPD | HI | DN | LOF | ? | LOF | DN | LOF | |
| Bacterial susceptibility | ✔ | | | ✔ | ✔ | ✔ | ? | | | | | ✔ | ✔ | | |
| Viral susceptibility | | ✔ | ✔ | ✔ | ✔ | | ✔ | | | ✔ | ✔ | ✔ | ✔ | ✔ | |
| Known pathogen range | Weakly virulent mycobacteria + Histoplasma capsulatum | HSV | Respiratory viral infections: Severe SARS-CoV-2 and influenza | P. jirovecii, vaccine strain BCG, M. bovis, CMV, EBV, … (see Table 2) | CMV, HSV, VZV, oral mycosis, G. lamblia, onychomycosis, … (see Table 2) | Tw | Rotavirus, C. albicans, HSV, respiratory infections (unknown cause) | No known infection susceptibility | No known infection susceptibility | Respiratory viral infections: severe SARS-CoV-2 and influenza + RSV, TBE virus, and adenovirus | Respiratory viral infections: severe SARS-CoV-2 and influenza | Weakly virulent mycobacteria | Respiratory viral infections: severe SARS-CoV-2 and influenza + eight other viruses (see Table 2) | ||
| + EBV, influenza, C. albicans, rhinovirus, HPV, CMV, and mycoplasma | + EBV, HPV, recurrent Clostridium difficile | ||||||||||||||
| Cellular abnormalities | CD4+ T cells | ↑↓ | | | ↓ | ↑↓ | | ↑↓ | | | | | ↓ | ↑ | ↓ |
| CD8+ T cells | ↑↓ | | | | ↑↓ | | ↓ | | | | | ↓ | | | |
| NK cells | ↓↓ | | | | | | | | | | | ↓ | | ↓ | |
| B cells | ↑ | | | ↓↓ | ↓ | | ↓ | | | | | ↓ | ↓ | ↓ | |
| DCs | ↓ | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↓ | | |
| Monocytes | | | | | | | ↑↓ | | | | | ↓↓/↓↓↓ | ↑ | | |
| IFN impairment | IFN-γ | IFN-α/β | IFN-α/β | IFN-γ | | IFN-γ | IFN-γ | | | IFN-α/β/λ1 | IFN-α/β | IFN-γ | IFN-α | IFN-α | |
| Gene expression defect | ↓ | ↓ | ↓ | ↑↓ | ↑↓ | ↓ | ↓ | Likely ↓ | ↓ | ↓ | ↓ | ↓ | ↓ | ||
| Other defects | Reduced innate lymphoid precursors | | | Hypogammaglobulinemia | Hypogammaglobulinemia, premature hair graying | | Agammaglobulinemia, hypereosinophilia, and hemophagocytosis | Lip pits and CLP | Lip pits, CLP, popliteal webbing, syndactyly, hypodontia, and deformities of the limbs and genitals | Impaired viral control in fibroblasts and pulmonary epithelia | Impaired IAV control in macrophages | Increased hypofunctional granulocytes. Intracerebral calcification and developmental delay | Mild neutrophilia | Impaired IAV control in fibroblasts, hypogammaglobulinemia | |
| Gene | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inheritance pattern | AR | AD (HSE) | AD | AD (T95R) | AD (F359L) | AD (R98W) | AR (V405Gfs | AD (VWS) | AD (PPS) | AR | AD | AR | AD | AR | |
| Mechanism | LOF | HI | HI | MM | MM | HI | UPD | HI | DN | LOF | ? | LOF | DN | LOF | |
| Bacterial susceptibility | ✔ | | | ✔ | ✔ | ✔ | ? | | | | | ✔ | ✔ | | |
| Viral susceptibility | | ✔ | ✔ | ✔ | ✔ | | ✔ | | | ✔ | ✔ | ✔ | ✔ | ✔ | |
| Known pathogen range | Weakly virulent mycobacteria | HSV | Respiratory viral infections: Severe SARS-CoV-2 and influenza | CMV, HSV, VZV, oral mycosis, | Tw | Rotavirus, | No known infection susceptibility | No known infection susceptibility | Respiratory viral infections: severe SARS-CoV-2 and influenza | Respiratory viral infections: severe SARS-CoV-2 and influenza | Weakly virulent mycobacteria | Respiratory viral infections: severe SARS-CoV-2 and influenza | |||
| + EBV, influenza, | + EBV, HPV, recurrent | ||||||||||||||
| Cellular abnormalities | CD4+ T cells | | | | | | | | |||||||
| CD8+ T cells | | | | | | | | | | | |||||
| NK cells | | | | | | | | | | | | ||||
| B cells | | | | | | | | ||||||||
| DCs | | | | | | | | | | | |||||
| Monocytes | | | | | | | | | | | | ||||
| IFN impairment | IFN-γ | IFN-α/β | IFN-α/β | IFN-γ | | IFN-γ | IFN-γ | | | IFN-α/β/λ1 | IFN-α/β | IFN-γ | IFN-α | IFN-α | |
| Gene expression defect | Likely | ||||||||||||||
| Other defects | Reduced innate lymphoid precursors | | | Hypogammaglobulinemia | Hypogammaglobulinemia, premature hair graying | | Agammaglobulinemia, hypereosinophilia, and hemophagocytosis | Lip pits and CLP | Lip pits, CLP, popliteal webbing, syndactyly, hypodontia, and deformities of the limbs and genitals | Impaired viral control in fibroblasts and pulmonary epithelia | Impaired IAV control in macrophages | Increased hypofunctional granulocytes. Intracerebral calcification and developmental delay | Mild neutrophilia | Impaired IAV control in fibroblasts, hypogammaglobulinemia | |
HI, haploinsufficiency; DN, dominant negative; MM, multimorphic; HSE, herpes simplex encephalitis; LOF, loss of function; TBE, tick-borne encephalitis; cellular abnormalities, abnormal count/function; IFN impairment, abnormal production/response; ↑, elevated; ↓, reduced; ↑↓, mixed effect or variable by genotype. See Table 2 for a detailed characterization of each IE-IRF.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Please sign in to your personal account to gift article access.
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.
Gift articles remaining: --
As a benefit of your subscription, you can share temporary access to restricted articles.
Each link will stop working after 30 days or 10 uses.
You have reached the limit of 10 links within a 30 day period.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.